Valuation: DexCom, Inc.

Market Cap 32.69B 171B 28.85B 27.3B 24.76B 46.42B 3,137B 46.87B 327B 126B 1,602B 123B 120B 5,155B P/E 2026 *
34.7x
P/E 2027 * 29.2x
Enterprise Value 31.93B 167B 28.18B 26.66B 24.18B 45.34B 3,064B 45.78B 320B 123B 1,565B 120B 117B 5,035B EV / Sales 2026 *
6.11x
EV / Sales 2027 * 5.45x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day-2.69%
1 week-1.63%
Current month-4.03%
1 month-3.72%
3 months+24.11%
6 months+37.90%
Current year+20.96%
1 week 8.94
Extreme 8.94
9.13
1 month 8.49
Extreme 8.49
9.51
Current year 5.75
Extreme 5.75
9.57
1 year 5.75
Extreme 5.75
9.57
3 years 5.75
Extreme 5.75
14.45
5 years 5.75
Extreme 5.75
18.3
10 years 5.75
Extreme 5.75
18.3
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
-2.69%-1.63% - - 32.69B
-0.03%-2.64%-24.16%+4.23% 175B
-2.69%-4.05%-7.32%+11.14% 111B
+1.25%-2.17%-0.15%+70.92% 58.7B
+1.87%+2.27%+15.58%+56.10% 49.27B
-1.01%-0.56%-1.10%-29.61% 49.57B
-0.05%-3.23%+30.36%-7.14% 32.69B
-0.26%+1.60% - - 30.69B
+0.26%+1.49%+44.68%+0.38% 26.51B
+0.28%+5.23%+26.98%-3.89% 23.95B
Average +0.20%+0.08%+10.61%+12.77% 61.94B
Weighted average by Cap. +0.49%-1.37%-2.86%+13.52%

Financials

2026 *2027 *
Net sales 5.23B 27.39B 4.62B 4.37B 3.96B 7.43B 502B 7.5B 52.39B 20.19B 256B 19.64B 19.21B 825B 5.8B 30.37B 5.12B 4.84B 4.39B 8.23B 557B 8.32B 58.1B 22.39B 284B 21.78B 21.3B 915B
Net income 974M 5.1B 860M 814M 738M 1.38B 93.5B 1.4B 9.76B 3.76B 47.74B 3.66B 3.58B 154B 1.15B 6.02B 1.01B 959M 870M 1.63B 110B 1.65B 11.51B 4.44B 56.3B 4.31B 4.22B 181B
Net Debt -761M -3.99B -672M -636M -576M -1.08B -73.04B -1.09B -7.62B -2.94B -37.3B -2.86B -2.8B -120B -1.06B -5.56B -937M -886M -804M -1.51B -102B -1.52B -10.63B -4.1B -52.01B -3.99B -3.9B -167B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
29/09/26 BRL 9.060 +1.34% 2
25/09/26 BRL 8.940 -2.08% 2
24/09/26 BRL 9.130 +0.33% 12
23/09/26 BRL 9.100 -1.19% 44
22/09/26 BRL 9.210 +1.21% 4
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
86.64USD
Average target price
94.48USD
Spread / Average Target
+9.05%

Quarterly revenue - Rate of surprise